This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Jan;5(1):3-6.

doi: 10.2450/2007.0b18-06.

Forty years of anti-D immunoprophylaxis

PMID: 19204744
PMCID: PMC2535875
DOI: 10.2450/2007.0b18-06

Editorial

Forty years of anti-D immunoprophylaxis

Giorgio Reali. Blood Transfus. 2007 Jan.

. 2007 Jan;5(1):3-6.

doi: 10.2450/2007.0b18-06.

Author

PMID: 19204744
PMCID: PMC2535875
DOI: 10.2450/2007.0b18-06

No abstract available

PubMed Disclaimer

Similar articles

Rh Immunoprophylaxis for Women With a Serologic Weak D Phenotype.
Virk M, Sandler SG. Virk M, et al. Lab Med. 2015 Summer;46(3):190-4. doi: 10.1309/LMUNUP4FJTUX2GCD. Lab Med. 2015. PMID: 26199257 Review.
[Anti-D sensitizations in the Leipzig District recorded in 1980 and 1981 and their relation to IgG-anti-D(Rh0) immunoprophylaxis].
Berge H. Berge H. Folia Haematol Int Mag Klin Morphol Blutforsch. 1983;110(1):133-45. Folia Haematol Int Mag Klin Morphol Blutforsch. 1983. PMID: 6192048 German.
Mycobacterium indicus pranii vaccine immunoprophylaxis in anti-phenolic glycolipid-1-positive leprosy contacts - A pilot study from a tertiary care center in North India.
Kumaran MS, Narang T, Chabbra S, Ashraf R, Dogra S. Kumaran MS, et al. Indian J Dermatol Venereol Leprol. 2021 Jan-Feb;88(1):47-50. doi: 10.25259/IJDVL_882_18. Indian J Dermatol Venereol Leprol. 2021. PMID: 34379957
[Justification of the need to normalize vitamin D status for immunoprophylaxis].
Tulegenova DE, Ibrayeva LK, Rybalkina DK, Minbayeva LS, Bacheva IV. Tulegenova DE, et al. Vopr Pitan. 2020;89(6):70-81. doi: 10.24411/0042-8833-2020-10080. Epub 2020 Nov 20. Vopr Pitan. 2020. PMID: 33476500 Review. Russian.
[Effectiveness of immunoprophylaxis in negative Rhesus factor].
Kotzbach R, Kłyszejko C, Sobociński Z, Włodarczyk L, Kotzbach M. Kotzbach R, et al. Ginekol Pol. 2000 Aug;71(8):859-62. Ginekol Pol. 2000. PMID: 11082937 Polish.

See all similar articles

Cited by

Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.
Xie X, Fu Q, Bao Z, Zhang Y, Zhou D. Xie X, et al. PLoS One. 2020 Mar 12;15(3):e0230073. doi: 10.1371/journal.pone.0230073. eCollection 2020. PLoS One. 2020. PMID: 32163467 Free PMC article.
Survey on the prevention and incidence of haemolytic disease of the newborn in Italy.
Bennardello F, Curciarello G. Bennardello F, et al. Blood Transfus. 2013 Oct;11(4):518-27. doi: 10.2450/2013.0179-12. Epub 2013 Jun 14. Blood Transfus. 2013. PMID: 23867179 Free PMC article.
Cytometry and Rhesus: not only for haemolytic disease of the newborn.
Martini C, Patroncini S, Mighetto L, Audino A, Girardi P, Giachino O, Natale G. Martini C, et al. Blood Transfus. 2011 Jan;9(1):104-6. doi: 10.2450/2010.0027-10. Epub 2010 Sep 14. Blood Transfus. 2011. PMID: 21084004 Free PMC article. No abstract available.
Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion.
Arthur CM, Patel SR, Smith NH, Bennett A, Kamili NA, Mener A, Gerner-Smidt C, Sullivan HC, Hale JS, Wieland A, Youngblood B, Zimring JC, Hendrickson JE, Stowell SR. Arthur CM, et al. J Immunol. 2017 Apr 1;198(7):2671-2680. doi: 10.4049/jimmunol.1601736. Epub 2017 Mar 1. J Immunol. 2017. PMID: 28250159 Free PMC article.
Predicting anti-RhD titers in donors: Boostering response and decline rates are personal.
de Vos AS, van der Schoot CE, Rizopoulos D, Janssen MP. de Vos AS, et al. PLoS One. 2018 Apr 26;13(4):e0196382. doi: 10.1371/journal.pone.0196382. eCollection 2018. PLoS One. 2018. PMID: 29698437 Free PMC article.

See all "Cited by" articles

References

1. Velati C. A survey of the current use of anti-D immunoprophylaxis and the incidence of haemolytic disease of the newborn in Italy. Blood Transfus. 2007;5:7–14. - PMC - PubMed
1. Levine P, Katzin EM, Burnham L. Isoimmunization in pregnancy, its possible bearing on the etiology of erythroblastosis fetalis. JAMA. 1941;116:825–7.
1. Wallerstein H. Treatment of severe erythroblastosis by simultaneous removal and replacement of blood of the newborn. Science. 1946;103:583–4. - PubMed
1. Finn R. Report of a meeting at the Liverpool Medical Institution: February 18th 1960. Lancet. 1960;i:526.
1. Finn R, Clarke CA, Donohue WTA, et al. Experimental studies on the prevention of Rh haemolytic disease. Br Med J. 1961;I:1486–90. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources